![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 11, 9309-9317, March 14, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
¶, and
**
From Ataxia-telangiectasia Mutated (ATM), mutated in
the human disorder ataxia-telangiectasia, is rapidly activated by DNA
double strand breaks. The mechanism of activation remains unresolved, and it is uncertain whether autophosphorylation contributes to activation. We describe an in vitro immunoprecipitation
system demonstrating activation of ATM kinase from unirradiated
extracts by preincubation with ATP. Activation is both time- and ATP
concentration-dependent, other nucleotides fail to activate
ATM, and DNA is not required. ATP activation is specific for ATM since
it is not observed with kinase-dead ATM, it requires Mn2+,
and it is inhibited by wortmannin. Exposure of activated ATM to
phosphatase abrogates activity, and repeat cycles of ATP and phosphatase treatment reveal a requirement for autophosphorylation in
the activation process. Phosphopeptide mapping revealed similarities between the patterns of autophosphorylation for irradiated and ATP-treated ATM. Caffeine inhibited ATM kinase activity for substrates but did not interfere with ATM autophosphorylation. ATP failed to activate either A-T and rad3-related protein (ATR) or
DNA-dependent protein kinase under these conditions,
supporting the specificity for ATM. These data demonstrate that ATP can
specifically induce activation of ATM by a mechanism involving
autophosphorylation. The relationship of this activation to DNA damage
activation remains unclear but represents a useful model for
understanding in vivo activation.
The Queensland Institute of Medical Research, PO
Royal Brisbane Hospital, Herston Qld 4029, Australia,
§ EIRX Therapeutics Ltd., Cork, Airport Business Park, Cork,
Ireland, the ¶ Queensland Radium Institute, Mater Hospital,
Brisbane Qld 4101, Australia, and the
Department of Surgery,
University of Queensland, PO Royal Brisbane Hospital,
Herston QLD 4029, Australia
This article has been cited by other articles:
![]() |
D. Watling, C. R. Carmo, I. M. Kerr, and A. P. Costa-Pereira Multiple kinases in the interferon-{gamma} response PNAS, April 22, 2008; 105(16): 6051 - 6056. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Stagni, M. G. di Bari, S. Cursi, I. Condo, M. T. Cencioni, R. Testi, Y. Lerenthal, E. Cundari, and D. Barila ATM kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells Blood, January 15, 2008; 111(2): 829 - 837. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Iwahori, N. Shirata, Y. Kawaguchi, S. K. Weller, Y. Sato, A. Kudoh, S. Nakayama, H. Isomura, and T. Tsurumi Enhanced Phosphorylation of Transcription Factor Sp1 in Response to Herpes Simplex Virus Type 1 Infection Is Dependent on the Ataxia Telangiectasia-Mutated Protein J. Virol., September 15, 2007; 81(18): 9653 - 9664. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shreeram, W. K. Hee, O. N. Demidov, C. Kek, H. Yamaguchi, A. J. Fornace Jr., C. W. Anderson, E. Appella, and D. V. Bulavin Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase J. Exp. Med., December 25, 2006; 203(13): 2793 - 2799. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kirshner, M. F. Jobling, M. J. Pajares, S. A. Ravani, A. B. Glick, M. J. Lavin, S. Koslov, Y. Shiloh, and M. H. Barcellos-Hoff Inhibition of Transforming Growth Factor-{beta}1 Signaling Attenuates Ataxia Telangiectasia Mutated Activity in Response to Genotoxic Stress Cancer Res., November 15, 2006; 66(22): 10861 - 10869. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Cohen, S. E. Pollack, and J. W. Pollard Genetic Analysis of Chromosome Pairing, Recombination, and Cell Cycle Control during First Meiotic Prophase in Mammals Endocr. Rev., June 1, 2006; 27(4): 398 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gueven, O. J. Becherel, G. Birrell, P. Chen, G. DelSal, J. P. Carney, P. Grattan-Smith, and M. F. Lavin Defective p53 Response and Apoptosis Associated with an Ataxia-Telangiectasia-like Phenotype. Cancer Res., March 15, 2006; 66(6): 2907 - 2912. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li and D. F. Stern Regulation of CHK2 by DNA-dependent Protein Kinase J. Biol. Chem., March 25, 2005; 280(12): 12041 - 12050. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Peng, R. G. Woods, H. Beamish, R. Ye, S. P. Lees-Miller, M. F. Lavin, and J. S. Bedford Deficiency in the Catalytic Subunit of DNA-Dependent Protein Kinase Causes Down-Regulation of ATM Cancer Res., March 1, 2005; 65(5): 1670 - 1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yan, A. B. Desai, J. W. Jacobberger, R. M. Sramkoski, T. Loh, and T. J. Kinsella CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses Mol. Cancer Ther., September 1, 2004; 3(9): 1147 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gueven, O. J. Becherel, A. W. Kijas, P. Chen, O. Howe, J. H. Rudolph, R. Gatti, H. Date, O. Onodera, G. Taucher-Scholz, et al. Aprataxin, a novel protein that protects against genotoxic stress Hum. Mol. Genet., May 15, 2004; 13(10): 1081 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Block, D. Merkle, K. Meek, and S. P. Lees-Miller Selective inhibition of the DNA-dependent protein kinase (DNA-PK) by the radiosensitizing agent caffeine Nucleic Acids Res., April 1, 2004; 32(6): 1967 - 1972. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Ward, K. Minn, and J. Chen UV-induced Ataxia-telangiectasia-mutated and Rad3-related (ATR) Activation Requires Replication Stress J. Biol. Chem., March 12, 2004; 279(11): 9677 - 9680. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Block, Y. Yu, and S. P. Lees-Miller Phosphatidyl inositol 3-kinase-like serine/threonine protein kinases (PIKKs) are required for DNA damage-induced phosphorylation of the 32 kDa subunit of replication protein A at threonine 21 Nucleic Acids Res., February 10, 2004; 32(3): 997 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ali, J. Zhang, S. Bao, I. Liu, D. Otterness, N. M. Dean, R. T. Abraham, and X.-F. Wang Requirement of protein phosphatase 5 in DNA-damage-induced ATM activation Genes & Dev., February 1, 2004; 18(3): 249 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Harris and J. C. Lawrence Jr. TOR Signaling Sci. Signal., December 9, 2003; 2003(212): re15 - re15. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang, Y. Yu, H. E. Hamrick, and P. J. Duerksen-Hughes ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses Carcinogenesis, October 1, 2003; 24(10): 1571 - 1580. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cortez Caffeine Inhibits Checkpoint Responses without Inhibiting the Ataxia-Telangiectasia-mutated (ATM) and ATM- and Rad3-related (ATR) Protein Kinases J. Biol. Chem., September 26, 2003; 278(39): 37139 - 37145. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |